生物活性 | |||
---|---|---|---|
描述 | Nitrofurantoin is an old antibiotic and an important first-line oral antibiotic for the treatment of uncomplicated urinary tract infections. Nitrofurantoin is not a uniform product -crystal sizes of nitrofurantoin, and therefore pharmacokinetic properties, differ significantly by product[3]. A broad spectrum of liver toxicity associated with nitrofurantoin use has been reported, ranging from acute hepatitis, granulomatous reaction, cholestasis, or autoimmune-mediated hepatitis to chronic active hepatitis that could lead to cirrhosis or death[4]. On the basis of urinary nitrofurantoin excretion determined after oral and intravenous drug administration, orally administered nitrofurantoin in a suitable dosage form is well absorbed[5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03466502 | Clostridium Difficile Infectio... 展开 >>n 收起 << | Phase 4 | Enrolling by invitation | March 2019 | United States, Nevada ... 展开 >> Renown Regional Medical Center Reno, Nevada, United States, 89502 收起 << |
NCT01349738 | - | Unknown | May 2013 | United States, California ... 展开 >> Scripps Green Hospital La Jolla, California, United States, 92037 收起 << | |
NCT03508921 | Overactive Bladder ... 展开 >> Urinary Tract Infections 收起 << | Phase 4 | Recruiting | September 1, 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.20mL 0.84mL 0.42mL |
20.99mL 4.20mL 2.10mL |
41.99mL 8.40mL 4.20mL |
参考文献 |
---|